<DOC>
	<DOCNO>NCT01647932</DOCNO>
	<brief_summary>The purpose study determine whether combine diuretic therapy ( loop diuretic thiazide-type diuretic ) effective ( term improve fluid overload symptom ) among patient decompensated heart failure comparison loop diuretic alone .</brief_summary>
	<brief_title>Safety Efficacy Combination Loop With Thiazide-type Diuretics Patients With Decompensated Heart Failure</brief_title>
	<detailed_description>Volume overload important clinical target heart failure management , typically address use loop diuretic . An important challenging subset heart failure patient exhibit fluid overload despite significant dos loop diuretic . One approach overcome loop diuretic resistance addition thiazide-type diuretic produce diuretic synergy via `` sequential nephron blockade , '' first describe 40 year ago . Although potentially able induce diuresis patient otherwise resistant high dos loop diuretic , strategy subject large-scale clinical trial establish safety clinical efficacy . Combination diuretic therapy use several thiazide-type diuretic double daily urine sodium excretion induce weight loss edema resolution . To knowledge clinical trial design prove efficacy safety combine diuretic therapy ( commonly use therapy ) among patient decompensated heart failure .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Sodium Potassium Chloride Symporter Inhibitors</mesh_term>
	<criteria>History chronic heart failure Admission acute decompensated heart failure There prespecified inclusion criterion respect heart failure etiology and/or ejection fraction Receipt oral loop diuretic least 1 month hospitalization , dose 80 mg 240 mg daily case furosemide equivalent dose case different loop diuretic ( 20 mg torasemide 1 mg bumetanide consider equivalent 40 mg furosemide ) Other etiology fluid overload different heart failure Hyponatremia : symptomatic sodium value sodium level 125mmol/l Unstable patient : acute coronary syndrome , cardiogenic shock ICU admission . Patients require inotropic agent renal replacement therapy Life expectancy &lt; 6 month Prior treatment thiazidetype diuretic Aldosterone antagonist permit patient take longterm basis ( least 30 day randomisation ) Pregnancy breastfeed period Active alcoholism and/or substance abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Diuretics</keyword>
	<keyword>Diuretic resistance</keyword>
</DOC>